Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-06

Clinical Trial Update: Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years Old [Phase 4]

View source ↗

Summary

Phase 4 trial update on safety and immunogenicity of Skyvaricella injection in healthy Vietnamese children aged 12 months to 12 years.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SkyVaricella (NBP608)

Snippet

Sponsor: Vietnam Military Medical University | Conditions: Chickenpox | Phase 4 | Status: COMPLETED